GlobalData
GlobalData is a leading provider of data, analytics, and insights on the world's largest industries.
See below for the Latest GlobalData News, Analysis, Profit Results, Share Price Information, and Commentary.
China's ophthalmic laser market eyes 4% CAGR growth until 2033
China's ophthalmic laser market eyes 4% CAGR growth until 2033
The country accounted for 25% of the Asia-Pacific market in 2024.
India’s diabetes care devices market eyes 4% CAGR growth until 2033
Thanks to increasing awareness, technological adoption, and improved information access.
Obesity treatment faces challenges in access and awareness: report
The disease’s prevalence is expected to grow 0.7% annually across seven major markets.
Diagnosed prostate cancer cases across 8MM to hit 4.24 million in 2033
The rise is partly attributed to the increased survival rate due to modern medicine.
AI solutions gain traction amidst healthcare workforce challenges
The tech tackles challenges like fall prevention, patient elopement, and staff burnout.
What’s in line for India’s transcatheter aortic valve replacement market?
A high burden of heart valve diseases is driving its expansion.
China’s digital health sector poised for growth amidst AI developments
However, data security must be upheld.
7MM parkinson’s disease market to hit $7.9b by 2033
The number of diagnosed cases is expected to rise to 3.1 million.
Australia’s oncology devices market to witness 3% CAGR until 2033
It accounted for 10% of the Asia Pacific market in 2024.
China's intraocular lens market to see 2% CAGR until 2033
Its expansion is attributed to the rising prevalence of myopia.
Alzheimer’s disease market across 8MM to hit 19.3b by 2033
DMTs are expected to account for 73.5% of the global market.
HIV-diagnosed cases in major markets projected to hit 2.2 million by 2033
Japan will have the fewest cases at around 34,400.
Heart failure market across 7MM to grow at 9.6% CAGR until 2032
One driver is the introduction of drugs targeting unmet needs.
Alzheimer’s disease cases in 8MM to reach 22.51 million by 2033
China is expected to witness the highest prevalence with an estimated 10.4 million cases.
T1D market in seven major markets to reach $9.9b by 2033
Thanks to the expected introduction of several late-stage pipeline products.
Challenges remain in treating T2-low asthma
Current treatments focus on eosinophilic asthma, neglecting non-eosinophilic types.
Immuno-oncology drugs poised for breakthrough in cancer treatment
Nearly 50% of experts expect this to have the most promising innovation pipeline.
Most Read
1. India’s Ankura Hospitals opens 120-bed super speciality hospital in Indore 2. Malaysia healthcare kept at Market Weight as earnings outpace revenue 3. China’s 15th Five‑Year Plan elevates medtech, brain‑computer interfaces 4. China's internet healthcare pivots to AI disease management 5. China's liver cancer cases to hit 264,000 by 2034Resource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
Demand was strong for AI-driven and digital healthcare solutions.
Commentary
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings